Silver Book Fact

Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.

Innovation in the Biopharmaceutical Pipeline: A multidimensional view. http://www.phrma.org/sites/default/files/pdf/2013innovationinthebiopharmaceuticalpipeline-analysisgroupfinal.pdf. Published 2013

Reference

Title
Innovation in the Biopharmaceutical Pipeline: A multidimensional view.
Publisher
Analysis Group
Publication Date
Published 2013
Authors
Long, G and J Works
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Since the war on cancer was declared in 1971, our arsenal has tripled. New drugs accounted for around 50-60% of the increase in six-year cancer survival rates since 1975.…  
  • Incidence rates for colorectal cancer have been decreasing since 1985, from 66 to 52 per 100,000 in 2002.  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.  
  • A mammogram can detect breast cancer 1-3 years before a woman can feel a lump. Mammography screening for women 50 and older can reduce breast cancer mortality by 30%.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.